Design for a Mail Survey to Determine Prevalence of SARS-CoV-2 (COVID-19) Antibodies in the United States. SRM [Internet]. 2020 Jun. 2 [cited 2026 Jul. 26];14(2):131-9. Available from: https://ojs.ub.uni-konstanz.de/srm/article/view/7757